Royal Bank of Canada’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-47,425
| Closed | -$942K | – | 7976 |
|
|
2023
Q1 | $942K | Sell |
47,425
-216,139
| -82% | -$3.73M | ﹤0.01% | 3384 |
|
|
2022
Q4 | $3.59M | Buy |
263,564
+22,840
| +9% | +$318K | ﹤0.01% | 2393 |
|
|
2022
Q3 | $3.34M | Buy |
240,724
+18,909
| +9% | +$281K | ﹤0.01% | 2418 |
|
|
2022
Q2 | $3.19M | Buy |
221,815
+34,115
| +18% | +$592K | ﹤0.01% | 2472 |
|
|
2022
Q1 | $4.24M | Buy |
187,700
+88,376
| +89% | +$1.72M | ﹤0.01% | 2395 |
|
|
2021
Q4 | $1.86M | Buy |
99,324
+22,137
| +29% | +$591K | ﹤0.01% | 3219 |
|
|
2021
Q3 | $2.53M | Buy |
77,187
+7,734
| +11% | +$289K | ﹤0.01% | 2875 |
|
|
2021
Q2 | $2.96M | Buy |
69,453
+13,495
| +24% | +$528K | ﹤0.01% | 2720 |
|
|
2021
Q1 | $2.15M | Sell |
55,958
-14,223
| -20% | -$605K | ﹤0.01% | 2941 |
|
|
2020
Q4 | $3.07M | Buy |
70,181
+6,348
| +10% | +$239K | ﹤0.01% | 2554 |
|
|
2020
Q3 | $2.51M | Buy |
63,833
+15,184
| +31% | +$490K | ﹤0.01% | 2500 |
|
|
2020
Q2 | $1.53M | Buy |
48,649
+16,597
| +52% | +$620K | ﹤0.01% | 2835 |
|
|
2020
Q1 | $1.13M | Buy |
32,052
+12,251
| +62% | +$516K | ﹤0.01% | 2933 |
|
|
2019
Q4 | $962K | Buy |
19,801
+559
| +3% | +$25.5K | ﹤0.01% | 3475 |
|
|
2019
Q3 | $914K | Sell |
19,242
-10,453
| -35% | -$491K | ﹤0.01% | 3415 |
|
|
2019
Q2 | $1.27M | Sell |
29,695
-1,841
| -6% | -$71.5K | ﹤0.01% | 3110 |
|
|
2019
Q1 | $1.22M | Sell |
31,536
-4,747
| -13% | -$161K | ﹤0.01% | 3058 |
|
|
2018
Q4 | $1.03M | Buy |
36,283
+5,270
| +17% | +$167K | ﹤0.01% | 3138 |
|
|
2018
Q3 | $1.21M | Buy |
31,013
+1,586
| +5% | +$58.6K | ﹤0.01% | 3210 |
|
|
2018
Q2 | $952K | Buy |
29,427
+2,016
| +7% | +$55.5K | ﹤0.01% | 3269 |
|
|
2018
Q1 | $601K | Buy |
27,411
+11,128
| +68% | +$268K | ﹤0.01% | 3574 |
|
|
2017
Q4 | $385K | Sell |
16,283
-6,040
| -27% | -$152K | ﹤0.01% | 3969 |
|
|
2017
Q3 | $629K | Buy |
22,323
+10,028
| +82% | +$305K | ﹤0.01% | 3617 |
|
|
2017
Q2 | $396K | Sell |
12,295
-6,609
| -35% | -$201K | ﹤0.01% | 3840 |
|
|
2017
Q1 | $535K | Sell |
18,904
-371
| -2% | -$9.85K | ﹤0.01% | 3587 |
|
|
2016
Q4 | $467K | Buy |
19,275
+2,175
| +13% | +$53.4K | ﹤0.01% | 3809 |
|
|
2016
Q3 | $406K | Sell |
17,100
-900
| -5% | -$19.7K | ﹤0.01% | 3883 |
|
|
2016
Q2 | $331K | Sell |
18,000
-4,000
| -18% | -$62.5K | ﹤0.01% | 4028 |
|
|
2016
Q1 | $228K | Sell |
22,000
-4,707
| -18% | -$47.7K | ﹤0.01% | 4279 |
|
|
2015
Q4 | $403K | Sell |
26,707
-16,668
| -38% | -$247K | ﹤0.01% | 3977 |
|
|
2015
Q3 | $687K | Buy |
43,375
+14,224
| +49% | +$359K | ﹤0.01% | 3203 |
|
|
2015
Q2 | $771K | Buy |
29,151
+13,845
| +90% | +$447K | ﹤0.01% | 3159 |
|
|
2015
Q1 | $598K | Sell |
15,306
-1,725
| -10% | -$59.4K | ﹤0.01% | 3341 |
|
|
2014
Q4 | $512K | Buy |
17,031
+2,050
| +14% | +$58.6K | ﹤0.01% | 3531 |
|
|
2014
Q3 | $354K | Buy |
14,981
+1,100
| +8% | +$31.3K | ﹤0.01% | 3782 |
|
|
2014
Q2 | $433K | Buy |
13,881
+2,371
| +21% | +$68.4K | ﹤0.01% | 3554 |
|
|
2014
Q1 | $366K | Sell |
11,510
-690
| -6% | -$22.8K | ﹤0.01% | 3593 |
|
|
2013
Q4 | $418K | Sell |
12,200
-2,978
| -20% | -$86.6K | ﹤0.01% | 3563 |
|
|
2013
Q3 | $305K | Buy |
15,178
+828
| +6% | +$17.2K | ﹤0.01% | 3776 |
|
|
2013
Q2 | $304K | Buy |
+14,350
| New | +$279K | ﹤0.01% | 3566 |
|
Other funds holding CSII
Royal Bank of Canada's CSII Position: Q2 2023 in Review
Royal Bank of Canada sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 47,425 shares — an estimated $942K sold.
Royal Bank of Canada first reported a position in CSII in Q2 2013 and held it in 40 quarters. The position peaked at $4.24M in Q1 2022. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.
- Royal Bank of Canada reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
- Royal Bank of Canada sold 47,425 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $942K.
- Royal Bank of Canada first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 40 quarters.
- Royal Bank of Canada's Cardiovascular Systems, Inc. position peaked at $4.24M in Q1 2022.
- 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.